(19)
(11) EP 4 816 561 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24896702.8

(22) Date of filing: 29.11.2024
(51) International Patent Classification (IPC): 
C12Q 1/6886(2018.01)
C12Q 1/6858(2018.01)
C12Q 1/6869(2018.01)
C12Q 1/68(2018.01)
C12Q 1/6883(2018.01)
G16B 20/00(2019.01)
C12Q 1/6806(2018.01)
(52) Cooperative Patent Classification (CPC):
G16B 30/10; G16B 20/20; C12Q 2600/154; G16H 50/20; C12Q 1/6806; C12Q 1/6886; C12Q 1/6874; C12Q 1/686
(86) International application number:
PCT/CN2024/135572
(87) International publication number:
WO 2025/113619 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 29.11.2023 US 202363604167 P

(71) Applicant: Centre for Novostics
Hong Kong (HK)

(72) Inventors:
  • LO, Yuk-Ming Dennis
    Hong Kong (CN)
  • CHAN, Kwan Chee
    Hong Kong (CN)
  • JIANG, Peiyong
    Hong Kong (CN)
  • ZHOU, Qing
    Hong Kong (CN)
  • PENG, Wenlei
    Hong Kong (CN)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) ENRICHMENT OF CLINICALLY-RELEVANT NUCLEIC ACIDS